Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cordlife Group ( (SG:P8A) ) has issued an announcement.
Cordlife Group Limited has announced a correction regarding the name of its subsidiary, which was inaccurately listed in previous annual reports. The subsidiary’s correct name, ‘Shanghai Cordlife Stem Cell Research Co., Ltd,’ will be accurately reflected in future reports, ensuring clarity and accuracy for shareholders.
More about Cordlife Group
Cordlife Group Limited is a company registered in Singapore, operating in the healthcare industry. It focuses on stem cell research and related biomedical services, serving a market that values advancements in medical technology and healthcare solutions.
Average Trading Volume: 161,388
Technical Sentiment Signal: Buy
Current Market Cap: S$68.93M
Learn more about P8A stock on TipRanks’ Stock Analysis page.